Abbott starts TriClip study amid rising competition for heart valve repair

Abbott starts TriClip study amid rising competition for heart valve repair is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-07-29

Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.

Source: MedTech Dive